A Study to Compare to the Pharmacokinetic Profile of Two Paracetamol Formulations

Completed · Phase 1

Conditions studied: Healthy Subjects

In brief

A repeat dose pharmacokinetic study investigating two paracetamol formulations

Key facts

Study ID

NCT01476189

Run by

GlaxoSmithKline

People needed

28

Starts

2009-11-01

Expected to finish

2009-12-01

Last updated by the study team

2014-11-24

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Good general health with (in the opinion of the investigator) no clinically significant and relevant abnormalities of medical history or physical examination.

You may not qualify if…

• Subject does not agree to refrain from alcohol consumption for the 10-day period prior to visit 2 and throughout the study.
• Participation in another clinical study or receipt of an investigational drug within 30 days of the screening visit.
• Current (within 14 days of screening) or regular use of any prescription, over-the-counter drugs including paracetamol/acetaminophen, herbal medicine or drug known to induce or inhibit hepatic drug metabolism in the 30 days prior to dosing (e.g. barbiturates, theophylline, cimetidine, or erythromycin), excluding prescription birth control, if applicable.

Where it is running

• MDS Pharma Services NEBRASKA — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.